/
© 2026 RiffOn. All rights reserved.

Get your free personalized podcast brief

We scan new podcasts and send you the top 5 insights daily.

  1. This Week in Startups
  2. This Bittensor Subnet Could Cut Drug Discovery Costs in HALF | E2267
This Bittensor Subnet Could Cut Drug Discovery Costs in HALF | E2267

This Bittensor Subnet Could Cut Drug Discovery Costs in HALF | E2267

This Week in Startups · Mar 26, 2026

This episode explores three Bittensor subnets creating real-world value in drug discovery (Metanova), the creator economy (BitCast), and AI vision (Score).

Biotech Startups Can Slash Costs by Using FDA Treaties for Overseas Clinical Trials

A treaty between the FDA and Brazil's health department allows clinical trials conducted in Brazil to be accepted by the FDA. This provides a pathway for biotech startups to drastically reduce R&D costs and accelerate timelines without compromising the "gold standard" of US regulatory approval.

This Bittensor Subnet Could Cut Drug Discovery Costs in HALF | E2267 thumbnail

This Bittensor Subnet Could Cut Drug Discovery Costs in HALF | E2267

This Week in Startups·2 months ago

Metanova Abstracts Complex Drug Discovery into a Search Problem, Unlocking Non-Expert Innovation

Instead of requiring deep scientific expertise, Metanova frames its drug discovery challenges as a search problem. This allows miners from diverse technical backgrounds to apply novel optimization strategies from other fields, leading to breakthroughs that industry insiders might overlook.

This Bittensor Subnet Could Cut Drug Discovery Costs in HALF | E2267 thumbnail

This Bittensor Subnet Could Cut Drug Discovery Costs in HALF | E2267

This Week in Startups·2 months ago

Decentralized Drug Discovery Platform Metanova Treats Adversarial Miners as a Feature, Not a Bug

Anonymous miners on the Bittensor network try to game Metanova's system to maximize rewards. This "unruly" behavior is beneficial, as it exposes weaknesses and low-confidence areas in state-of-the-art models, ultimately making the system more resilient and robust than a closed, internal R&D process.

This Bittensor Subnet Could Cut Drug Discovery Costs in HALF | E2267 thumbnail

This Bittensor Subnet Could Cut Drug Discovery Costs in HALF | E2267

This Week in Startups·2 months ago

Decentralized Creator Platform BitCast Activates the High-Engagement Long Tail of Influencers

Brands typically focus on mega-influencers due to the high administrative cost of managing many small creators. BitCast automates the entire campaign process, removing this friction. This allows brands to efficiently tap into the "99%" of smaller creators, who often have higher trust and engagement with their audiences.

This Bittensor Subnet Could Cut Drug Discovery Costs in HALF | E2267 thumbnail

This Bittensor Subnet Could Cut Drug Discovery Costs in HALF | E2267

This Week in Startups·2 months ago

Manico's SaaS Platform Abstracts Complex Bittensor Mechanics into a Simple Chat Interface

Manico provides a user-friendly frontend for the Score subnet. Customers can describe their computer vision needs in a simple prompt, and the platform agentically builds a full pipeline—from fine-tuning the best miner-created model to deployment—without the user needing any knowledge of computer vision or blockchain technology.

This Bittensor Subnet Could Cut Drug Discovery Costs in HALF | E2267 thumbnail

This Bittensor Subnet Could Cut Drug Discovery Costs in HALF | E2267

This Week in Startups·2 months ago

BitCast's AI-Verified Campaigns Enable Single-Click Global, Multilingual Creator Marketing

BitCast's platform uses AI to verify that creator content adheres to a campaign brief, regardless of the language. This unique capability allows a brand to launch a campaign across hundreds of creators in different languages simultaneously, a task that would traditionally require multiple international teams and massive administrative effort.

This Bittensor Subnet Could Cut Drug Discovery Costs in HALF | E2267 thumbnail

This Bittensor Subnet Could Cut Drug Discovery Costs in HALF | E2267

This Week in Startups·2 months ago

The Bittensor Network Structures AI Development as a Perpetual, 24/7 Hackathon

Bittensor subnets operate like continuous, global competitions where miners constantly strive to solve challenges set by subnet owners, and validators score their performance. This "hackathon that never sleeps" model creates a relentless, decentralized engine for innovation and optimization across diverse AI applications like drug discovery and social media.

This Bittensor Subnet Could Cut Drug Discovery Costs in HALF | E2267 thumbnail

This Bittensor Subnet Could Cut Drug Discovery Costs in HALF | E2267

This Week in Startups·2 months ago

Score's Bittensor Subnet Distills Giant Vision Models into Tiny, CPU-Runnable Experts

Score addresses the high cost of AI vision by using a decentralized network of miners to "distill" massive, general-purpose models (e.g., 3.4GB) into hyper-specialized, tiny models (e.g., 50MB). This allows complex vision tasks to run on local CPUs, unlocking use cases previously blocked by prohibitive GPU costs.

This Bittensor Subnet Could Cut Drug Discovery Costs in HALF | E2267 thumbnail

This Bittensor Subnet Could Cut Drug Discovery Costs in HALF | E2267

This Week in Startups·2 months ago